268 related articles for article (PubMed ID: 27739361)
1. Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs.
Joanitti GA; Ganassin R; Rodrigues MC; Figueiro Longo JP; Jiang CS; Gu J; Leal Pinto SM; Almeida Dos Santos MF; de Azevedo RB; Muehlmann LA
Mini Rev Med Chem; 2017; 17(3):224-236. PubMed ID: 27739361
[TBL] [Abstract][Full Text] [Related]
2. An update on applications of nanostructured drug delivery systems in cancer therapy: a review.
Aberoumandi SM; Mohammadhosseini M; Abasi E; Saghati S; Nikzamir N; Akbarzadeh A; Panahi Y; Davaran S
Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-11. PubMed ID: 27632797
[TBL] [Abstract][Full Text] [Related]
3. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
Taurin S; Nehoff H; Greish K
J Control Release; 2012 Dec; 164(3):265-75. PubMed ID: 22800576
[TBL] [Abstract][Full Text] [Related]
4. Organelle targeting: third level of drug targeting.
Sakhrani NM; Padh H
Drug Des Devel Ther; 2013; 7():585-99. PubMed ID: 23898223
[TBL] [Abstract][Full Text] [Related]
5. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled mirror DNA nanostructures for tumor-specific delivery of anticancer drugs.
Kim KR; Kim HY; Lee YD; Ha JS; Kang JH; Jeong H; Bang D; Ko YT; Kim S; Lee H; Ahn DR
J Control Release; 2016 Dec; 243():121-131. PubMed ID: 27746274
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology applied to overcome tumor drug resistance.
Gao Z; Zhang L; Sun Y
J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
[TBL] [Abstract][Full Text] [Related]
8. Nanopreparations for organelle-specific delivery in cancer.
Biswas S; Torchilin VP
Adv Drug Deliv Rev; 2014 Feb; 66():26-41. PubMed ID: 24270008
[TBL] [Abstract][Full Text] [Related]
9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
10. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
11. Advances in Nanocarriers for Anticancer Drugs Delivery.
Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors.
Thangavel P; Viswanath B; Kim S
Int J Nanomedicine; 2017; 12():2749-2758. PubMed ID: 28435255
[TBL] [Abstract][Full Text] [Related]
13. Nanomaterials in cancer-therapy drug delivery system.
Zhang G; Zeng X; Li P
J Biomed Nanotechnol; 2013 May; 9(5):741-50. PubMed ID: 23802404
[TBL] [Abstract][Full Text] [Related]
14. Membrane-core nanoparticles for cancer nanomedicine.
Guo J; Huang L
Adv Drug Deliv Rev; 2020; 156():23-39. PubMed ID: 32450105
[TBL] [Abstract][Full Text] [Related]
15. Future of nanotherapeutics: Targeting the cellular sub-organelles.
Ma X; Gong N; Zhong L; Sun J; Liang XJ
Biomaterials; 2016 Aug; 97():10-21. PubMed ID: 27155363
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of platinum-based anticancer complexes.
Butler JS; Sadler PJ
Curr Opin Chem Biol; 2013 Apr; 17(2):175-88. PubMed ID: 23395452
[TBL] [Abstract][Full Text] [Related]
17. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
Sun X; Zhang G; Wu Z
Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
[TBL] [Abstract][Full Text] [Related]
18. Design and application of DNA nanostructures for organelle-targeted delivery of anticancer drugs.
Sun S; Yang Y; Niu H; Luo M; Wu ZS
Expert Opin Drug Deliv; 2022 Jun; 19(6):707-723. PubMed ID: 35618266
[TBL] [Abstract][Full Text] [Related]
19. Implications of nanotechnology for the treatment of cancer: Recent advances.
Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents.
Anaya-Ruiz M; Bandala C; Landeta G; Martínez-Morales P; Zumaquero-Rios JL; Sarracent-Pérez J; Pérez-Santos M
Recent Pat Anticancer Drug Discov; 2019; 14(1):85-94. PubMed ID: 30381087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
